EUVIMEDEUVIMED entdecken
Crossref

Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies

Fritz Sedlazeck

The Biomedical & Life Sciences Collection · 29.10.2026 · 2026 (10) · e1008422

DOI: 10.69645/xqjb5671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 29.10.2026. Verfasst von Fritz Sedlazeck.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sedlazeck, F. (2026). Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies. The Biomedical & Life Sciences Collection, 2026(10), e1008422. https://doi.org/10.69645/xqjb5671

Vancouver

Sedlazeck F. Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies. The Biomedical & Life Sciences Collection. 2026;2026(10):e1008422. doi:10.69645/xqjb5671

BibTeX
@article{Sedlazeck2026,
  author = {Sedlazeck, Fritz},
  title = {Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies},
  journal = {The Biomedical & Life Sciences Collection},
  year = {2026},
  volume = {2026},
  number = {10},
  pages = {e1008422},
  doi = {10.69645/xqjb5671}
}
Kostenlos starten →